Abstract
Background:There is limited experience in treating infective endocarditis (IE) with outpatient parenteral antibiotic therapy (OPAT).Methods:Following institutional review board (IRB) approval, patients discharged from Baystate Medical Center with IE documented by modified Duke criteria treated with OPAT were identified. Data obtained included organisms implicated, indications of clinical stability, percentage of total therapy rendered after hospitalization, and one year follow up.Results:Forty-three patients met criteria. Thirty-five percent were infected with staphylococci; 38% harbored streptococci or enterococci. Native valves and left-sided valves each constituted approximately 75% of total. All patients received >4 weeks of therapy, with >66% rendered after hospital discharge A median of 7 days of hemodynamic stability and negative blood cultures occurred prior to discharge. After one year, no patients died from IE. Twenty-three percent were hospitalized during OPAT from intravenous catheter, antibiotic, or other complications, but none for direct complications of IE.Conclusions:OPAT for IE can be safely utilized, and at least 66% of care can be given in this manner. Our investigation provides enhanced data on employing OPAT for IE caused by staphylococci, left-sided infections, and also provides outcomes after one year after treatment.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Rehm SJ. Outpatient intravenous antibiotic therapy for endocarditis. Infect Dis Clin North Am 1998;12:879–901.RehmSJOutpatient intravenous antibiotic therapy for endocarditis.Infect Dis Clin North Am199812879-9012. Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998;98:2936–2948.BayerAS]]BolgerAF]]TaubertKA&etal;Diagnosis and management of infective endocarditis and its complications.Circulation1998982936-29483. Durack DT. Evaluating and optimizing outcomes of surgery for endocarditis. JAMA 2003;290:3250–3251.DurackDTEvaluating and optimizing outcomes of surgery for endocarditis.JAMA20032903250-32514. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345:1318–1330.MylonakisE]]CalderwoodSBInfective endocarditis in adults.N Engl J Med20013451318-13305. Salgado AV, Furlan AJ, Keys TF, et al. Neurologic complications of endocarditis: a 12-year experience. Neurology 1989;39:173–178.SalgadoAV]]FurlanAJ]]KeysTF&etal;Neurologic complications of endocarditis: a 12-year experience.Neurology198939173-1786. Mills J, Utley J, Abbott J. Heart failure in infective endocarditis: predisposing factors, course, and treatment. Chest 1974;66:151–157.MillsJ]]UtleyJ]]AbbottJHeart failure in infective endocarditis: predisposing factors, course, and treatment.Chest197466151-1577. Monteiro CA, Cobbs CG. Outpatient management of infective endocarditis. Curr Infect Dis Rep 2001;3:319–327.MonteiroCA]]CobbsCGOutpatient management of infective endocarditis.Curr Infect Dis Rep20013319-3278. Steckelberg JM, Murphy JG, Ballard D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991;114:635–640.SteckelbergJM]]MurphyJG]]BallardD&etal;Emboli in infective endocarditis: the prognostic value of echocardiography.Ann Intern Med1991114635-6409. Vilacosta I, Graupner C, San Román JA, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002;39:1489–1495.VilacostaI]]GraupnerC]]San RománJA&etal;Risk of embolization after institution of antibiotic therapy for infective endocarditis.J Am Coll Cardiol2002391489-149510. Stamboulian D. Outpatient treatment of endocarditis in a clinic-based program in Argentina. Eur J Clin Microbiol Infect Dis 1995;14:648–654.StamboulianDOutpatient treatment of endocarditis in a clinic-based program in Argentina.Eur J Clin Microbiol Infect Dis199514648-65411. Wilson WR. Ceftriaxone sodium therapy of penicillin G-susceptible streptococcal endocarditis. JAMA 1992;267:279–280.WilsonWRCeftriaxone sodium therapy of penicillin G-susceptible streptococcal endocarditis.JAMA1992267279-28012. Brown RB, Sands M. Outpatient intravenous antibiotic therapy. Am Fam Physician 1989;40:157–162.BrownRB]]SandsMOutpatient intravenous antibiotic therapy.Am Fam Physician198940157-16213. Brown RB. Prescribing antibiotics in home health care: problems and prospects. Geriatrics 1988;43:43–46, 49.14. Brown RB. Selection and training of patients for outpatient intravenous antibiotic therapy. Rev Infect Dis 1991;13(suppl 2):S147–S151.BrownRBSelection and training of patients for outpatient intravenous antibiotic therapy.Rev Infect Dis199113S147-S15115. Brown RB. Outpatient parenteral therapy. Management of serious infections. Part I: medical, socioeconomic, and legal issues. Selecting the patient. Hosp Pract (Off Ed) 1993;28(suppl 1):11–15.BrownRBOutpatient parenteral therapy. Management of serious infections. Part I: medical, socioeconomic, and legal issues. Selecting the patient.Hosp Pract (Off Ed)19932811-1516. Durack DT. Outpatient parenteral antibiotic therapy. Management of serious infections. Part II: amenable infections and models for delivery. Endocarditis. Hosp Pract (Off Ed) 1993;28(suppl 2):6–9; discussion 56.17. Matthews PC, Conlon CP, Berendt AR, et al. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 2007;60:356–362.MatthewsPC]]ConlonCP]]BerendtAR&etal;Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.J Antimicrob Chemother200760356-36218. Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004;38:1651–1672.TiceAD]]RehmSJ]]DalovisioJR&etal;Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines.Clin Infect Dis2004381651-167219. Huminer D, Bishara J, Pitlik S. Home intravenous antibiotic therapy for patients with infective endocarditis. Eur J Clin Microbiol Infect Dis 1999;18:330–334.HuminerD]]BisharaJ]]PitlikSHome intravenous antibiotic therapy for patients with infective endocarditis.Eur J Clin Microbiol Infect Dis199918330-33420. Stamboulian D, Bonvehi P, Arevalo C, et al. Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Rev Infect Dis 1991;13(suppl 2):S160–S163.StamboulianD]]BonvehiP]]ArevaloC&etal;Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci.Rev Infect Dis199113S160-S16321. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394–e434.BaddourLM]]WilsonWR]]BayerAS&etal;Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.Circulation2005111e394-e43422. Hill EE, Peetermans WE, Vanderschueren S, et al. Methicillin-resistant versus methicillin-sensitive staphylococcus aureus infective endocarditis. Eur J Clin Microbiol Infect Dis 2008;27:445–450.HillEE]]PeetermansWE]]VanderschuerenS&etal;Methicillin-resistant versus methicillin-sensitive staphylococcus aureus infective endocarditis.Eur J Clin Microbiol Infect Dis200827445-45023. Sherwood M, Smith D, Crisel R, et al. Staphylococcus aureus endocarditis: the Grady Memorial Hospital Experience. Am J Med Sci 2006;331:84–87.SherwoodM]]SmithD]]CriselR&etal;Staphylococcus aureus endocarditis: the Grady Memorial Hospital Experience.Am J Med Sci200633184-8724. Yoon HJ, Choi JY, Kim CO, et al. A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis. Yonsei Med J 2005;46:496–502.YoonHJ]]ChoiJY]]KimCO&etal;A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis.Yonsei Med J200546496-50225. Delahaye F, Alla F, Beguinot I, et al. In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis 2007;39:849–857.DelahayeF]]AllaF]]BeguinotI&etal;In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period.Scand J Infect Dis200739849-85726. Cabell CH, Pond KK, Peterson GE, et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001;142:75–80.CabellCH]]PondKK]]PetersonGE&etal;The risk of stroke and death in patients with aortic and mitral valve endocarditis.Am Heart J200114275-8027. Andrews MM, von Reyn CF. Patient selection criteria and management guidelines for outpatient parenteral intravenous antibiotic therapy for native valve infective endocarditis. Clin Infect Dis 2001;33:203–209.AndrewsMM]]von ReynCFPatient selection criteria and management guidelines for outpatient parenteral intravenous antibiotic therapy for native valve infective endocarditis.Clin Infect Dis200133203-20928. Pulcini C, Couadau T, Bernard E, et al. Adverse effects of parenteral antimicrobial therapy for chronic bone infections. Eur J Clin Microbiol Infect Dis 2008;27:1227–1232.PulciniC]]CouadauT]]BernardE&etal;Adverse effects of parenteral antimicrobial therapy for chronic bone infections.Eur J Clin Microbiol Infect Dis2008271227-123229. Antoniskis A, Anderson BC, Van Volkinburg EJ, et al. Feasibility of outpatient self-administration of parenteral antibiotics. West J Med 1978;128:203–206.AntoniskisA]]AndersonBC]]Van VolkinburgEJ&etal;Feasibility of outpatient self-administration of parenteral antibiotics.West J Med1978128203-206
